|
Wyeth, Schwarz Found Not Liable For Injuries From Generic Reglan
A federal court has ruled that Wyeth and Schwarz Pharma cannot be held responsible for injuries suffered by a patient who took a generic version of the gastroesophageal reflux disease treatment Reglan.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
Union Suit Claims Warner Chilcott Schemed to Stall Generics, Push Weaker Product Teva Prepping for Potential $2 Billion Loss in Protonix Patent FlapLawmakers to SCOTUS: Congress Purposely Did Not Preempt Drugmakers From State SuitsPhRMA Joins Generic Makers in Calling for SCOTUS Reversal of Mutual Decision
|
Subscribe
Archives